Using the median PFKFB3 expression level as a cutoff, HCC patients were stratified into PFKFB3high (n = 43) and PFKFB3low (n = 44) cohorts for subsequent clinicopathological analysis. The gene discussed is PFKFB3; the disease is hepatocellular carcinoma.